2022. Development Of Pretomanids And Their Therapeutic Uses In The Treatment Of Tuberculosis. Journal of Pharmaceutical Negative Results. 13, (Nov. 2022), 2307–2313. DOI:https://doi.org/10.47750/pnr.2022.13.S05.362.